{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T11:42:58Z","timestamp":1784115778055,"version":"3.55.0"},"reference-count":62,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.exer.2023.109436","type":"journal-article","created":{"date-parts":[[2023,3,11]],"date-time":"2023-03-11T01:54:42Z","timestamp":1678499682000},"page":"109436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Development and application of animal models to study thyroid-associated ophthalmopathy"],"prefix":"10.1016","volume":"230","author":[{"given":"Feiyang","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lianfei","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huifang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.exer.2023.109436_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1167\/tvst.9.8.26","article-title":"Characterization of a murine model of oxazolone-induced orbital inflammation","volume":"9","author":"Amarnani","year":"2020","journal-title":"Transl Vis Sci Technol"},{"issue":"8","key":"10.1016\/j.exer.2023.109436_bib2","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.exer.2023.109436_bib3","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1210\/en.2013-1705","article-title":"News and views: at long last, an animal model of Graves' orbitopathy","volume":"154","author":"Bahn","year":"2013","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib4","first-page":"168","article-title":"Management of Graves' ophthalmopathy: reality and perspectives","volume":"21","author":"Bartalena","year":"2000","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.exer.2023.109436_bib5","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"European group on Graves' orbitopathy (EUGOGO). The 2016 European thyroid association\/European group on Graves' orbitopathy guidelines for the management of Graves' orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"issue":"4","key":"10.1016\/j.exer.2023.109436_bib6","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"10.1016\/j.exer.2023.109436_bib7","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1210\/en.2015-1829","article-title":"Comparative assessment of female mouse model of Graves' orbitopathy under different environments, accompanied by proinflammatory cytokine and T-cell responses to thyrotropin hormone receptor antigen","volume":"157","author":"Berchner-Pfannschmidt","year":"2016","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.exer.2023.109436_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/aps.2013.133","article-title":"Diosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease","volume":"35","author":"Cai","year":"2014","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1172\/JCI0215745","article-title":"Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor","volume":"110","author":"Chazenbalk","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.exer.2023.109436_bib10","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/jon.12858","article-title":"Aberrant brain voxel-wise resting state fMRI in patients with thyroid-associated ophthalmopathy","volume":"31","author":"Chen","year":"2021","journal-title":"J. Neuroimaging"},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib11","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1006\/bbrc.1994.1332","article-title":"Induction of thyrotropin receptor (TSH-R) autoantibodies and thyroiditis in mice immunised with the recombinant TSH-R","volume":"199","author":"Costagliola","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"11","key":"10.1016\/j.exer.2023.109436_bib12","doi-asserted-by":"crossref","first-page":"4637","DOI":"10.1210\/endo.137.11.8895327","article-title":"Transfer of thyroiditis, with syngeneic spleen cells sensitized with the human thyrotropin receptor, to naive BALB\/c and NOD mice","volume":"137","author":"Costagliola","year":"1996","journal-title":"Endocrinology"},{"issue":"6","key":"10.1016\/j.exer.2023.109436_bib13","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1172\/JCI7665","article-title":"Genetic immunization of outbred mice with thyrotropin receptor cDNA provides a model of Graves' disease","volume":"105","author":"Costagliola","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 1","key":"10.1016\/j.exer.2023.109436_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1159\/000508790","article-title":"A novel long-term Graves' disease animal model confirmed by functional thyrotropin receptor antibodies","volume":"9","author":"Diana","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/j.exer.2023.109436_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102666","article-title":"A cyclic peptide significantly improves thyroid function, thyrotropin-receptor antibodies and orbital mucine\/collagen content in a long-term Graves' disease mouse model","volume":"122","author":"Diana","year":"2021","journal-title":"J. Autoimmun."},{"issue":"4","key":"10.1016\/j.exer.2023.109436_bib16","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.exer.2023.109436_bib17","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jamaophthalmol.2021.6284","article-title":"Proptosis and diplopia response with teprotumumab and placebo vs the recommended treatment regimen with intravenous methylprednisolone in moderate to severe thyroid eye disease: a meta-analysis and matching-adjusted indirect comparison","volume":"140","author":"Douglas","year":"2022","journal-title":"JAMA Ophthalmol"},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib18","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s12020-020-02311-7","article-title":"Lessons from mouse models of Graves' disease","volume":"68","author":"Eckstein","year":"2020","journal-title":"Endocrine"},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib19","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s40265-018-1045-9","article-title":"Current and emerging treatment strategies for Graves' orbitopathy","volume":"79","author":"Genere","year":"2019","journal-title":"Drugs"},{"issue":"7","key":"10.1016\/j.exer.2023.109436_bib20","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1210\/en.2016-1845","article-title":"Cyclic peptides for effective treatment in a long-term model of Graves disease and orbitopathy in female mice","volume":"158","author":"Holthoff","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.exer.2023.109436_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.exer.2021.108489","article-title":"Prostaglandin F2\u03b1 and EP2 agonists, and a ROCK inhibitor modulate the formation of 3D organoids of Grave's orbitopathy related human orbital fibroblasts","volume":"205","author":"Ichioka","year":"2021","journal-title":"Exp. Eye Res."},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.31083\/j.jin2002037","article-title":"Altered spontaneous brain activity patterns in dysthyroid optic neuropathy: a resting-state fMRI study","volume":"20","author":"Jiang","year":"2021","journal-title":"J. Integr. Neurosci."},{"issue":"1","key":"10.1016\/j.exer.2023.109436_bib23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/WCO.0000000000000894","article-title":"Optic neuropathy and diplopia from thyroid eye disease: update on pathophysiology and treatment","volume":"34","author":"Johnson","year":"2021","journal-title":"Curr. Opin. Neurol."},{"issue":"9","key":"10.1016\/j.exer.2023.109436_bib24","doi-asserted-by":"crossref","first-page":"5157","DOI":"10.4049\/jimmunol.163.9.5157","article-title":"Induction of experimental autoimmune Graves' disease in BALB\/c mice","volume":"163","author":"Kaithamana","year":"1999","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.exer.2023.109436_bib25","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1210\/en.2006-1077","article-title":"An improved Graves' disease model established by using in vivo electroporation exhibited long-term immunity to hyperthyroidism in BALB\/c mice","volume":"148","author":"Kaneda","year":"2007","journal-title":"Endocrinology"},{"issue":"6194","key":"10.1016\/j.exer.2023.109436_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/science.1247125","article-title":"Organogenesis in a dish: modeling development and disease using organoid technologies","volume":"345","author":"Lancaster","year":"2014","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.exer.2023.109436_bib27","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s13075-015-0725-z","article-title":"Investigation of the relationship between the onset of arthritis and uveitis in genetically predisposed SKG mice","volume":"17","author":"Lee","year":"2015","journal-title":"Arthritis Res. Ther."},{"issue":"31","key":"10.1016\/j.exer.2023.109436_bib28","doi-asserted-by":"crossref","first-page":"21001","DOI":"10.1074\/jbc.M109.002865","article-title":"LFA-1 regulates CD8+ T cell activation via T cell receptor-mediated and LFA-1-mediated Erk1\/2 signal pathways","volume":"284","author":"Li","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.exer.2023.109436_bib29","first-page":"45","article-title":"Icariin inhibits AMPK-dependent autophagy and adipogenesis in adipocytes in vitro and in a model of Graves' orbitopathy in vivo","volume":"8","author":"Li","year":"2017","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.exer.2023.109436_bib30","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.4049\/jimmunol.162.8.4966","article-title":"Development of an animal model of autoimmune thyroid eye disease","volume":"162","author":"Many","year":"1999","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.exer.2023.109436_bib31","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s40168-018-0478-4","article-title":"Gut microbiota in experimental murine model of Graves' orbitopathy established in different environments may modulate clinical presentation of disease","volume":"6","author":"Masetti","year":"2018","journal-title":"Microbiome"},{"issue":"6","key":"10.1016\/j.exer.2023.109436_bib32","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1210\/er.2004-0023","article-title":"Insight into Graves' hyperthyroidism from animal models","volume":"26","author":"McLachlan","year":"2005","journal-title":"Endocr. Rev."},{"issue":"9","key":"10.1016\/j.exer.2023.109436_bib33","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1210\/en.2013-1576","article-title":"Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation","volume":"154","author":"Moshkelgosha","year":"2013","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.exer.2023.109436_bib34","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40168-020-00952-4","article-title":"Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease","volume":"9","author":"Moshkelgosha","year":"2021","journal-title":"Microbiome"},{"issue":"1","key":"10.1016\/j.exer.2023.109436_bib35","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40168-020-00952-4","article-title":"Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease","volume":"9","author":"Moshkelgosha","year":"2021","journal-title":"Microbiome"},{"issue":"10","key":"10.1016\/j.exer.2023.109436_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/thy.2007.0161","article-title":"Graves' animal models of Graves' hyperthyroidism","volume":"17","author":"Nagayama","year":"2007","journal-title":"Thyroid"},{"issue":"6","key":"10.1016\/j.exer.2023.109436_bib37","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.4049\/jimmunol.168.6.2789","article-title":"A novel murine model of Graves' hyperthyroidism with intramuscular injection of adenovirus expressing the thyrotropin receptor","volume":"168","author":"Nagayama","year":"2002","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.exer.2023.109436_bib38","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/MED.0000000000000186","article-title":"Animal models of Graves' disease and Graves' orbitopathy","volume":"22","author":"Nagayama","year":"2015","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"8","key":"10.1016\/j.exer.2023.109436_bib39","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/en.2010-0315","article-title":"Enhanced response to mouse thyroid-stimulating hormone (TSH) receptor immunization in TSH receptor-knockout mice","volume":"151","author":"Nakahara","year":"2010","journal-title":"Endocrinology"},{"issue":"4","key":"10.1016\/j.exer.2023.109436_bib40","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1210\/en.2011-1846","article-title":"Adoptive transfer of antithyrotropin receptor (TSHR) autoimmunity from TSHR knockout mice to athymic nude mice","volume":"153","author":"Nakahara","year":"2012","journal-title":"Endocrinology"},{"issue":"3","key":"10.1016\/j.exer.2023.109436_bib41","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/anie.201409365","article-title":"Activatable 19F MRI nanoparticle probes for the detection of reducing environments","volume":"54","author":"Nakamura","year":"2015","journal-title":"Angew Chem. Int. Ed. Engl."},{"issue":"1","key":"10.1016\/j.exer.2023.109436_bib42","doi-asserted-by":"crossref","first-page":"7329","DOI":"10.1038\/s41598-020-64402-9","article-title":"Enhanced orbital adipogenesis in a mouse model of T-cell-mediated autoimmunity, zymosan A-treated SKG mice: implications for Graves' ophthalmopathy","volume":"10","author":"Park","year":"2020","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.exer.2023.109436_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/thy.2021.0464","article-title":"An early wave of macrophage infiltration intertwined with antigen-specific proinflammatory T cells and browning of adipose tissue characterizes the onset of orbital inflammation in a mouse model of Graves' orbitopathy","volume":"32","author":"Philipp","year":"2022","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.exer.2023.109436_bib44","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/thy.2021.0464","article-title":"An early wave of macrophage infiltration intertwined with antigen-specific proinflammatory T cells and browning of adipose tissue characterizes the onset of orbital inflammation in a mouse model of Graves' orbitopathy","volume":"32","author":"Philipp","year":"2022","journal-title":"Thyroid"},{"issue":"9","key":"10.1016\/j.exer.2023.109436_bib45","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1089\/thy.2018.0754","article-title":"Fingolimod improves the outcome of experimental Graves' disease and associated orbitopathy by modulating the autoimmune response to the thyroid-stimulating hormone receptor","volume":"29","author":"Pl\u00f6hn","year":"2019","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.exer.2023.109436_bib46","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2017.0430","article-title":"High serum cholesterol is a novel risk factor for Graves' orbitopathy: results of a cross-sectional study","volume":"28","author":"Sabini","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/j.exer.2023.109436_bib47","article-title":"The potential link between gut microbiota and serum TRAb in Chinese patients with severe and active Graves' orbitopathy","volume":"2019","author":"Shi","year":"2019","journal-title":"Internet J. Endocrinol."},{"key":"10.1016\/j.exer.2023.109436_bib48","article-title":"The potential link between gut microbiota and serum TRAb in Chinese patients with severe and active Graves' orbitopathy","volume":"2019","author":"Shi","year":"2019","journal-title":"Internet J. Endocrinol."},{"issue":"10","key":"10.1016\/j.exer.2023.109436_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23105603","article-title":"Tgf\u03b2-treated placenta-derived mesenchymal stem cells selectively promote anti-adipogenesis in thyroid-associated ophthalmopathy","volume":"23","author":"Shin","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.exer.2023.109436_bib50","article-title":"Neuroanatomic variations in Graves' dysthyroid ophthalmopathy as studied with MRI","volume":"114","author":"Silkiss","year":"2016","journal-title":"Trans. Am. Ophthalmol. Soc."},{"issue":"16","key":"10.1016\/j.exer.2023.109436_bib51","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.exer.2023.109436_bib52","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa511","article-title":"Gut dysbiosis contributes to the imbalance of treg and Th17 cells in Graves' disease patients by propionic acid","volume":"105","author":"Su","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.exer.2023.109436_bib53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/wnan.1163","article-title":"19F magnetic resonance imaging of endogenous macrophages in inflammation","volume":"4","author":"Temme","year":"2012","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148595","article-title":"Development of a novel thyroid function fluctuated animal model for thyroid-associated ophthalmopathy","volume":"11","author":"Tu","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148595","article-title":"Development of a novel thyroid function fluctuated animal model for thyroid-associated ophthalmopathy","volume":"11","author":"Tu","year":"2016","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s12016-016-8562-7","article-title":"Review of mouse models of Graves' disease and orbitopathy-novel treatment by induction of tolerance","volume":"52","author":"Ungerer","year":"2017","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"8","key":"10.1016\/j.exer.2023.109436_bib57","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1055\/s-0033-1343451","article-title":"Current insights into animal models of Graves' disease and orbitopathy","volume":"45","author":"Wiesweg","year":"2013","journal-title":"Horm. Metab. Res."},{"issue":"2","key":"10.1016\/j.exer.2023.109436_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.3109\/08916934.2011.611548","article-title":"The significance of immune-related molecule expression profiles in an animal model of Graves' disease","volume":"45","author":"Ye","year":"2012","journal-title":"Autoimmunity"},{"issue":"12","key":"10.1016\/j.exer.2023.109436_bib59","first-page":"1073","article-title":"[Establishment of an animal model for thyroid associated ophthalmopathy by treatment of mice with human thyrotropin receptors-activated splenocytes]","volume":"42","author":"Zhang","year":"2006","journal-title":"Zhonghua Yan Ke Za Zhi"},{"issue":"4","key":"10.1016\/j.exer.2023.109436_bib60","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/thy.2020.0088","article-title":"A promising mouse model of Graves' orbitopathy induced by adenovirus expressing thyrotropin receptor A subunit","volume":"31","author":"Zhang","year":"2021","journal-title":"Thyroid"},{"issue":"3","key":"10.1016\/j.exer.2023.109436_bib61","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/JOE-11-0162","article-title":"Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA","volume":"210","author":"Zhao","year":"2011","journal-title":"J. Endocrinol."},{"issue":"10","key":"10.1016\/j.exer.2023.109436_bib62","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.autrev.2010.05.021","article-title":"Clinical review about TRAb assay's history","volume":"9","author":"Z\u00f6phel","year":"2010","journal-title":"Autoimmun. Rev."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352300057X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S001448352300057X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T05:22:30Z","timestamp":1758000150000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S001448352300057X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":62,"alternative-id":["S001448352300057X"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2023.109436","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and application of animal models to study thyroid-associated ophthalmopathy","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2023.109436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"109436"}}